STAT3 and prostate carcinoma: In conclusion, this study provides a molecular basis for a novel role of genistein in simultaneously inhibiting the activation of STAT3 and other closely related oncogenic kinases, such as AKT, ERK, and p38, in prostate cancer DU145 cells (Figure 6).